Bank of Montreal’s CytRx Corp CYTR Stock Holding History

Bank of Montreal’s Portfolio CYTR Stock Details CYTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-82	Closed	–	–	5239
2019 Q1	$0	Hold	82	–	–	﹤0.01%	5109
2018 Q4	$0	Hold	82	–	–	﹤0.01%	5046
2018 Q3	$0	Hold	82	–	–	﹤0.01%	5042
2018 Q2	$0	Hold	82	–	–	﹤0.01%	5017
2018 Q1	$0	Hold	82	–	–	﹤0.01%	4525
2017 Q4	$0	Hold	82	–	–	﹤0.01%	4499
2017 Q3	$0	Hold	82	–	–	﹤0.01%	4483
2017 Q2	$0	Hold	82	–	–	﹤0.01%	4445
2017 Q1	$0	Hold	82	–	–	﹤0.01%	4373
2016 Q4	$0	Hold	82	–	–	﹤0.01%	4347
2016 Q3	$0	Hold	82	–	–	﹤0.01%	4380
2016 Q2	$1K	Sell	82 -53	-39%	-$881	﹤0.01%	4041
2016 Q1	$2K	Sell	135 -195	-59%	-$2.67K	﹤0.01%	4027
2015 Q4	$5K	Buy	330 +277	+523%	+$4.75K	﹤0.01%	3829
2015 Q3	$1K	Hold	53	–	–	﹤0.01%	3950
2015 Q2	$1K	Hold	53	–	–	﹤0.01%	3910
2015 Q1	$1K	Hold	53	–	–	﹤0.01%	3937
2014 Q4	$1K	Buy	+53	New	+$827	﹤0.01%	3993
2013 Q4	–	Sell	-179	Closed	-$3K	–	4155
2013 Q3	$3K	Buy	+179	New	+$2.64K	﹤0.01%	3660

Other funds holding CYTR

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

CTA

Colonial Trust Advisors Spartanburg, South Carolina $1.29B AUM 19.9% 1-Year Est. Return

Bank of Montreal's CYTR Position: Q2 2019 in Review

Bank of Montreal sold out of CytRx Corp (CYTR) in Q2 2019, closing a stake of 82 shares.

Bank of Montreal first reported a position in CYTR in Q3 2013 and held it in 19 quarters. The position peaked at $5K in Q4 2015. 5 funds tracked by Wall St. Rank hold CYTR as of Q2 2019.

Bank of Montreal reported no remaining CytRx Corp position as of Q2 2019 after selling out during the quarter.
Bank of Montreal sold 82 CytRx Corp shares in Q2 2019.
Bank of Montreal first reported a position in CytRx Corp in Q3 2013 and held it in 19 quarters.
Bank of Montreal's CytRx Corp position peaked at $5K in Q4 2015.
5 funds tracked by Wall St. Rank held CytRx Corp as of Q2 2019.

Based on Bank of Montreal's 13F filing for Q2 2019, filed 9 Aug 2019.